These data suggest that approaches to lower RBP4 levels, such as utilizing fenretinide or thiazolidinedione, could lead to new strategies to attenuate adipose tissue inflammation, ameliorating metabolic parameters and insulin resistance. Here, RBP4 is linked to Insulin resistance.